EFFECT OF ANTHRACYCLINE ANTITUMOR ANTIBIOTICS UPON TRANSCRIPTION ACTIVITY OF CANCER-TESTIS ANTIGENS IN MODEL EXPERIMENTS WITH HeLa CELLS
Cancer-testis antigens (CTA) can be used as a target for immunotherapy of various malignant tumors, including cervical cancer. However, immunotherapy is often used in combination with anthracycline chemotherapy, in particular, doxorubicin (DXR). Their effects upon expression of CTA genes have not be...
Guardado en:
Autores principales: | D. S. Kutilin, Kh. A. Mogushkova |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
SPb RAACI
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c3bb8df222704500bdd844391f9df59c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
TRANSCRIPTIONAL PROFILE OF CANCER-TESTICULAR ANTIGENS IN PATIENTS WITH BREAST CANCER
por: D. I. Vodolazhskiy, et al.
Publicado: (2018) -
Investigation of the Effects of Artemisinin on Testis and Kidney Injury Induced by Doxorubicin
por: Tutun Hidayet, et al.
Publicado: (2019) -
HeLa Cell-Derived Paclitaxel-Loaded Microparticles Efficiently Inhibit the Growth of Cervical Carcinoma
por: Peng J, et al.
Publicado: (2020) -
Nanotoxic Effects of Silver Nanoparticles on Normal HEK-293 Cells in Comparison to Cancerous HeLa Cell Line
por: Liu X, et al.
Publicado: (2021) -
Gold nanoparticles from Celastrus hindsii and HAuCl4: Green synthesis, characteristics, and their cytotoxic effects on HeLa cells
por: Mai Xuan-Truong, et al.
Publicado: (2021)